HIV/AIDS Research: Its History & Future Meeting
Page tree
Skip to end of metadata
Go to start of metadata

The iPrEx study (2007–2011) was the first phase III clinical trial to study the effectiveness of pre-exposure prophylaxis (PrEP).

See  Grant, Robert M., Javier R. Lama, Peter L. Anderson, Vanessa McMahan, Albert Y. Liu, Lorena Vargas, Pedro Goicochea, et al. “Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.” New England Journal of Medicine 363, no. 27 (December 30, 2010): 2587–99. doi:10.1056/NEJMoa1011205.

Found 3 search result(s) for iPrEx.

Page: 6.1 Sharon Hillier — Development and Application of Pre-exposure Prophylaxis (PrEP) (HIV/AIDS Research: Its History & Future Meeting)
... better uptake in some of the studies, just as we did with 00:31:00 iPrEx. After iPrEx, with IPERGAY and PROUD. I think that will make a huge difference. Emilio: That's what ... ...
Apr 27, 2021
Page: 2.3 Mark Harrington — The Importance of Activism to the US Response (HIV/AIDS Research: Its History & Future Meeting)
... very important trials that happened in the last 15 years, like HPTN 052 and iPrEx studies (of TasP and PrEP), and SMART (Strategies for Management of AntiRetroviral Therapy study, 2002 ...
Apr 27, 2021
Page: 6.7 Salim Abdool Karim — Stopping the Spread of HIV in Developing Countries (HIV/AIDS Research: Its History & Future Meeting)
... area at the same time as us, were starting to the release their results shortly thereafter. The iPrEx study, the Partners PrEP study. They were coming out in quick succession 00 ...
Apr 27, 2021

  • No labels